CDC recommends reinstating third Prevnar dose
Executive Summary
Health care providers should reinstate administration of third dose of Wyeth's pneumococcal conjugate vaccinePrevnar for healthy children under two years old, Centers for Disease Control & Prevention says July 8. CDC recommended suspending the third and fourth doses of Prevnar in March due to a "markedly worse" than anticipated production shortfall in Wyeth's vial-filling process (1"The Pink Sheet" March 8, 2004, p. 25). CDC expects that Prevnar supply will be adequate for four-dose coverage in the fall (2"The Pink Sheet" June 7, 2004, p.30)...